Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000406579

Medchemexpress LLC 1,6-Hexanediaminium, N1,N1,N1,N6,N6,N6-hexamethyl-, bromide (1:2) | 55-97-0 | 99.9% | 25 G
SDP

Catalog No. 5000406579
Encompass_Preferred

Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) with mixed competitive and noncompetitive activity. It possesses anti-hypertensive properties and has been shown to attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.

  • Non-selective ganglionic nicotinic-receptor antagonist (nAChR)
  • Exhibits mixed competitive and noncompetitive activity
  • Attenuates sympathetic activity and blood pressure
  • Targets apoptosis, cardiovascular disease, and neurological disease
  • Appears as a white to off-white solid

Catalog No. 50-004-06579 Supplier Medchemexpress LLC Supplier No. 25GHYB0569
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Hexamethonium Bromide is a non-selective ganglionic nicotinic-receptor antagonist (nAChR) with mixed competitive and noncompetitive activity. It possesses anti-hypertensive properties and has been shown to attenuate sympathetic activity and blood pressure in spontaneously hypertensive animal models.

  • Non-selective ganglionic nicotinic-receptor antagonist (nAChR)
  • Exhibits mixed competitive and noncompetitive activity
  • Attenuates sympathetic activity and blood pressure
  • Targets apoptosis, cardiovascular disease, and neurological disease
  • Appears as a white to off-white solid

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.